Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2025-07-07 00:00:00 ET · period of report 2025-06-24 · accession 0001213900-25-061772 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-07 | 2025-06-24 | TARA | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -300.0K | 659.9K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-24 | G | D | 300,000 | $0.00 | 659,886 | D | — | — | (F1) On June 24, 2025, the reporting person transferred 300,000 shares of common stock to The Samhold Family Trust for no consideration. Members of the reporting person's immediate family are the sole beneficiaries of the trust and a member of the reporting person's immediate family serves as a trustee thereof. The reporting person remains the beneficial owner of the securities held by the trust. |